Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Advanced Biomed Inc. (ADVB) had Return on Equity of -93.71% for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.26M |
|
-- |
|
-- |
|
$3.02M |
|
$-3.02M |
|
$-0.24M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.02M |
|
$-2.68M |
|
20.53M |
|
20.53M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$6.03M |
|
$0.33M |
|
$0.48M |
|
$6.51M |
|
$2.89M |
|
-- |
|
$0.15M |
|
$3.03M |
|
$3.48M |
|
$3.48M |
|
$3.48M |
|
21.64M |
|
| Cash Flow Statement Financials | |
$-5.83M |
|
$-0.03M |
|
$5.93M |
|
$2.61M |
|
$2.90M |
|
$0.30M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-93.71% |
-93.71% |
|
-50.04% |
|
-93.71% |
|
$0.16 |
|
$-0.29 |
|
$-0.28 |
|